Article
Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Scandinavian journal of immunology - 1 Dec 2004
Sugumaran G, Elliott-Bryant R, Phung N, Vitseva O, Kuberan B, Lech M
Abstract excerpt
The pathogenesis of the amyloid deposition diseases is poorly understood. The CE/J mouse, which is naturally protected from amyloid A (AA) protein amyloidosis, has provided a tool to study mechanisms that may be implicated in amyloid deposition diseases by means of comparison of findings with those in an AA-susceptible mouse strain. We have compared proteoglycan/glycosaminoglycan accumulation in vivo in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
